Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value: $768M (99.1% shares, 0.9% debt)

Holdings (17)

INGN INOGEN INC 43.9%

Value $338M Shares 3,549,320 Est. Cost $17.78 Unrealized +442.2%

— ACCELERON PHARMA INC 7.5%

Value $57.99M Shares 1,553,937 Est. Cost $27.65 Unrealized —

— DERMIRA INC 6.8%

Value $51.88M Shares 1,921,580 Est. Cost $30.22 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 6.7%

Value $51.71M Shares 3,244,046 Est. Cost $14.33 Unrealized -3.5%

ANAB ANAPTYSBIO INC 5.4%

Value $41.61M Shares 1,190,604 Est. Cost $23.32 Unrealized +15.7%

AKBA AKEBIA THERAPEUTICS INC 4.8%

Value $37.13M Shares 1,887,535 Est. Cost $10.82 Unrealized +42.1%

— FLEXION THERAPEUTICS INC 4.7%

Value $36.27M Shares 1,500,000 Est. Cost $16.59 Unrealized —

— RA PHARMACEUTICALS INC 3.9%

Value $29.66M Shares 2,031,562 Est. Cost $15.19 Unrealized —

— MERUS N V 3.6%

Value $28.02M Shares 1,410,417 Est. Cost $7.99 Unrealized —

— NABRIVA THERAPEUTICS PLC 3.1%

Value $23.78M Shares 2,903,800 Est. Cost $10.02 Unrealized —

— REATA PHARMACEUTICALS INC 2.4%

Value $18.44M Shares 592,794 Est. Cost $19.75 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 2.4%

Value $18.34M Shares 2,725,283 Est. Cost $7.37 Unrealized -3.3%

— INVUITY INC 1.6%

Value $12.14M Shares 1,363,848 Est. Cost $9.51 Unrealized —

— VERONA PHARMA PLC 1.5%

Value $11.37M Shares 740,740 Est. Cost $11.66 Unrealized —

— WRIGHT MED GROUP N V 0.9%

Value $7.164M Shares 4,622,032 Est. Cost $1.25 Unrealized —

CRSP CRISPR THERAPEUTICS AG 0.5%

Value $3.991M Shares 223,317 Est. Cost $18.69 Unrealized -3.0%

— APOLLO ENDOSURGERY INC 0.2%

Value $1.285M Shares 274,472 Est. Cost $12.16 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$338M	43.9%	$17.78	+442.2%	COM	45780L104
—	ACCELERON PHARMA INC	1,553,937	$57.99M	7.5%	$27.65	—	COM	00434H108
—	DERMIRA INC	1,921,580	$51.88M	6.8%	$30.22	—	COM	24983L104
CRVS	CORVUS PHARMACEUTICALS INC	3,244,046	$51.71M	6.7%	$14.33	-3.5%	COM	221015100
ANAB	ANAPTYSBIO INC	1,190,604	$41.61M	5.4%	$23.32	+15.7%	COM	032724106
AKBA	AKEBIA THERAPEUTICS INC	1,887,535	$37.13M	4.8%	$10.82	+42.1%	COM	00972D105
—	FLEXION THERAPEUTICS INC	1,500,000	$36.27M	4.7%	$16.59	—	COM	33938J106
—	RA PHARMACEUTICALS INC	2,031,562	$29.66M	3.9%	$15.19	—	COM	74933V108
—	MERUS N V	1,410,417	$28.02M	3.6%	$7.99	—	COM	N5749R100
—	NABRIVA THERAPEUTICS PLC	2,903,800	$23.78M	3.1%	$10.02	—	SHS	G63637105
—	REATA PHARMACEUTICALS INC	592,794	$18.44M	2.4%	$19.75	—	CL A	75615P103
KALV	KALVISTA PHARMACEUTICALS INC	2,725,283	$18.34M	2.4%	$7.37	-3.3%	COM	483497103
—	INVUITY INC	1,363,848	$12.14M	1.6%	$9.51	—	COM NEW	46187J205
—	VERONA PHARMA PLC	740,740	$11.37M	1.5%	$11.66	—	SPONSORED ADS	925050106
—	WRIGHT MED GROUP N V	4,622,032	$7.164M	0.9%	$1.25	—	RIGHT 03/01/2019	N96617126
CRSP	CRISPR THERAPEUTICS AG	223,317	$3.991M	0.5%	$18.69	-3.0%	NAMEN AKT	H17182108
—	APOLLO ENDOSURGERY INC	274,472	$1.285M	0.2%	$12.16	—	COM	03767D108